Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant

McGill University

$1,269,900.00

Redefining Parkinson's disease dementia: an in-depth investigation into the causal role of common co-pathologies

EF 2024-25

Résumé
Dementia is very common in Parkinson's, with up to 80% of patients developing dementia within the first ten years of disease. Despite its prevalence, the causes of dementia remain largely unknown and as a result, no effective treatments are available. The evolution and severity of cognitive dysfunction observed in Parkinson's disease varies a lot from one patient to the next. This suggests that different patients may have different causes for their dementia. Consistent with this, recent research has shown that some patients with Parkinson's disease who develop dementia also have evidence of other brain diseases known to cause dementia. In particular, Alzheimer's disease and vascular disease, which both cause dementia, are thought to co-exist with Parkinson's disease in some patients. However, exactly how much they contribute to dementia - above and beyond having Parkinson's disease - is unknown. The goals of this project are therefore to: 1.Determine if Alzheimer's disease causes dementia in individuals with Parkinson's disease. 2.Determine if vascular disease causes dementia in individuals with Parkinson's disease. 3.Identify ways to predict which individuals with Parkinson's disease will develop dementia due to one of these causes. To achieve these goals we will follow 275 Parkinson's patients over time. Patients will undergo detailed assessments, including cognitive testing, blood tests and MRI scans. Major recent scientific breakthroughs have led to new treatments for some forms of dementia, including Alzheimer's disease, but we don't know yet if these could be useful in Parkinson's disease. The results of this research could therefore drastically change the way we treat dementia in individuals with Parkinson's disease by proving that potentially modifiable brain diseases, separate from Parkinson's disease, also play a significant role in causing dementia in Parkinson's disease.
Programme
Project Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
524671
Name
Sharp Madeleine E
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Behavioural Sciences - B-2
Projecttitle
Redefining Parkinson's disease dementia: an in-depth investigation into the causal role of common co-pathologies
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$1,269,900
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Alzheimer'S Disease; Biomarkers; Cognition; Cognitive Reserve; Dementia; Mri; Parkinson'S Disease; Vascular Dementia
Abstract
Dementia is very common in Parkinson's, with up to 80% of patients developing dementia within the first ten years of disease. Despite its prevalence, the causes of dementia remain largely unknown and as a result, no effective treatments are available. The evolution and severity of cognitive dysfunction observed in Parkinson's disease varies a lot from one patient to the next. This suggests that different patients may have different causes for their dementia. Consistent with this, recent research has shown that some patients with Parkinson's disease who develop dementia also have evidence of other brain diseases known to cause dementia. In particular, Alzheimer's disease and vascular disease, which both cause dementia, are thought to co-exist with Parkinson's disease in some patients. However, exactly how much they contribute to dementia - above and beyond having Parkinson's disease - is unknown. The goals of this project are therefore to: 1.Determine if Alzheimer's disease causes dementia in individuals with Parkinson's disease. 2.Determine if vascular disease causes dementia in individuals with Parkinson's disease. 3.Identify ways to predict which individuals with Parkinson's disease will develop dementia due to one of these causes. To achieve these goals we will follow 275 Parkinson's patients over time. Patients will undergo detailed assessments, including cognitive testing, blood tests and MRI scans. Major recent scientific breakthroughs have led to new treatments for some forms of dementia, including Alzheimer's disease, but we don't know yet if these could be useful in Parkinson's disease. The results of this research could therefore drastically change the way we treat dementia in individuals with Parkinson's disease by proving that potentially modifiable brain diseases, separate from Parkinson's disease, also play a significant role in causing dementia in Parkinson's disease.
Competitiondate
202503
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Sharp, Madeleine E; Dagher, Alain; Postuma, Ronald B
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $1,269,900~ $0~